Search

Your search keyword '"David H Cribbs"' showing total 231 results

Search Constraints

Start Over You searched for: Author "David H Cribbs" Remove constraint Author: "David H Cribbs"
231 results on '"David H Cribbs"'

Search Results

1. Semi-automated protocol to quantify and characterize fluorescent three-dimensional vascular images.

2. Fas and Fas Ligand are associated with neuritic degeneration in the AD brain and participate in β-amyloid-induced neuronal death

3. Bapineuzumab alters aβ composition: implications for the amyloid cascade hypothesis and anti-amyloid immunotherapy.

4. Amyloid-β peptide binds to cytochrome C oxidase subunit 1.

5. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer's disease.

6. Reducing AD-like pathology in 3xTg-AD mouse model by DNA epitope vaccine - a novel immunotherapeutic strategy.

7. New insights into the genetic etiology of Alzheimer's disease and related dementias

8. Chronic kidney disease promotes cerebral microhemorrhage formation

9. Abstract TP223: Cerebral Microbleeds In Sickle Cell Disease

10. Abstract TP198: Periodontitis Enhances Cerebral Microhemorrhage Development In A Mouse Model Of Hypertension

11. MultiTEP‐based conjugated vaccines targeting various phosphorylated tau epitopes are immunogenic and effective in the PS19 mouse model

12. Immunogenicity of MultiTEP platform technology-based Tau vaccine in non-human primates

13. Modulation of hepatic amyloid precursor protein and lipoprotein receptor-related protein 1 by chronic alcohol intake: Potential link between liver steatosis and amyloid-β

14. The Effects of a Blood–Brain Barrier Penetrating Erythropoietin in a Mouse Model of Tauopathy

15. Semi-automated protocol to quantify and characterize fluorescent three-dimensional vascular images

16. Immunogenicity of MultiTEP-Platform-Based Recombinant Protein Vaccine, PV-1950R, Targeting Three B-Cell Antigenic Determinants of Pathological α-Synuclein

17. Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

19. Abstract TP127: Hypertension Provokes Development Of Cerebral Microhemorrhages In A Mouse Model

20. Abstract WP262: Three-dimensional Characterization Of Cerebral Microvasculature And Microhemorrhages

21. Abstract 87: Chronic Kidney Disease Induces Cerebral Microhemorrhages In Aged Mice

22. Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studies

23. The first MultiTEP‐based conjugated vaccine targeting pyroglutamated pE3‐Aβ is immunogenic and effective in a 5xFAD animal model

24. Cerebral Blood Flow in Chronic Kidney Disease

25. Hematologic safety of chronic brain-penetrating erythropoietin dosing in APP/PS1 mice

26. Spectroscopic and deep learning-based approaches to identify and quantify cerebral microhemorrhages

27. Simple methodology to visualize whole-brain microvasculature in three dimensions

28. Three-dimensional quantification of cerebral vasculature in mouse brains with confocal microscopy

29. Insights Into the Mechanisms of Brain Endothelial Erythrophagocytosis

30. Using Digital Pathology to Identify and Quantify Cerebral Microhemorrhages

31. Three-Dimensional Visualization and Quantitative Characterization of Cerebral Microvasculature in Mice

32. Active immunization with tau epitope in a mouse model of tauopathy induced strong antibody response together with improvement in short memory and pSer396-tau pathology

33. Aging exacerbates development of cerebral microbleeds in a mouse model

34. Blood–Brain Barrier Penetrating Biologic TNF-α Inhibitor for Alzheimer’s Disease

35. Comparison of Efficacy of Preventive and Therapeutic Vaccines Targeting the N Terminus of β-Amyloid in an Animal Model of Alzheimer’s Disease

36. Testing a MultiTEP-based combination vaccine to reduce Aβ and tau pathology in Tau22/5xFAD bigenic mice

37. A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice

38. Effects of Dabigatran in Mouse Models of Aging and Cerebral Amyloid Angiopathy

39. Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials

40. Brain Penetrating Bifunctional Erythropoietin-Transferrin Receptor Antibody Fusion Protein for Alzheimer's Disease

41. Chronic Kidney Disease Increases Cerebral Microbleeds in Mouse and Man

42. P3‐057: THERAPEUTIC EFFECTS OF A BRAIN PENETRATING BISPECIFIC ERYTHROPOIETIN‐TRANSFERRIN RECEPTOR ANTIBODY FUSION PROTEIN IN THE APP/PS1 MOUSE MODEL OF ALZHEIMER'S DISEASE

43. P2-165: HEMATOLOGIC SAFETY OF A BRAIN PENETRATING ERYTHROPOIETIN-TRANSFERRIN RECEPTOR ANTIBODY FUSION PROTEIN IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

44. Microglial Function in Intracerebral Hemorrhage Injury and Recovery

45. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

46. [O4–06–04]: PROTECTIVE EFFECTS OF A BRAIN‐PENETRATING BIOLOGIC TNF‐ALPHA INHIBITOR IN A MOUSE MODEL OF ALZHEIMER's DISEASE

47. [P1–101]: MULTITEP PLATFORM‐BASED DNA VACCINES FOR ALPHA‐SYNUCLEINOPATHIES: PRECLINICAL EVALUATION OF IMMUNOGENICITY AND THERAPEUTIC POTENCY

48. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer’s Disease

49. Abstract WMP75: Age- and Sex-Specific Development of Cerebral Microbleeds in a Mouse Model

50. Effects of phosphodiesterase 3A modulation on murine cerebral microhemorrhages

Catalog

Books, media, physical & digital resources